![]() |
市場調查報告書
商品編碼
1661061
黏合劑輔料市場報告,按產品類型(纖維素、乳糖、多元醇、聚維酮、澱粉和多醣、共加工可壓縮輔料等)、應用(片劑和膠囊、基於溶液)和地區分類,2025 年至 2033 年Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2025-2033 |
2024IMARC Group全球黏合劑輔料市場規模達到 15.3 億美元。大眾對口服藥物的需求不斷增加、對以患者為中心的配方的日益關注以及廣泛的研發活動是推動市場發展的一些關鍵因素。
黏合劑輔料是藥物製劑中的重要成分之一,尤其是在固體口服劑型中使用時。它們用於將藥物活性物質和藥片或膠囊中的其他成分結合在一起,從而產生穩定且易於管理的最終產品。它們是親水性分子,可以與配方中的其他成分(例如纖維素衍生物)產生強大的分子間相互作用。增強粉末混合物的壓縮性是黏合劑賦形劑的主要目的之一,它使藥片或膠囊盡可能保持恆定的大小和形狀,保證一致且可預測的劑量。此外,它們有助於增強粉末混合物的流動特性,使其更容易壓縮藥片或填充膠囊。它們還有助於控制活性成分的釋放,這是黏合劑賦形劑的另一個重要功能,同時它們有助於維持藥物的治療效果,這對於藥物具有有限的治療窗口或僅在身體的某些部位吸收至關重要。有多種類型的黏合劑賦形劑可供選擇,包括天然和合成聚合物、糖和澱粉
患者對口服藥物的需求不斷增加,主要推動了全球市場的發展。這是因為它們具有易於管理、方便和劑量準確等多種優點,從而推動了市場的發展。此外,許多製藥公司正在大力投資開發新的藥片和膠囊配方,這推動了對黏合劑輔料的需求。除此之外,人們越來越關注以患者為中心的配方,以提高患者對藥物治療方案的依從性和堅持性,這極大地支持了市場。同時,需要專門的黏合劑賦形劑的新型藥物傳輸系統(如緩釋片和膠囊)的開發也推動了需求。除此之外,對營養保健食品(具有健康益處的膳食補充劑)的需求不斷成長,對市場產生了積極影響。此外,隨著品牌藥物專利到期的數量不斷增加,對學名藥的需求也不斷增加,這也促進了市場的發展。此外,共加工輔料等新型輔料的開發正在創造積極的市場前景。推動市場發展的其他因素包括對創新療法的需求不斷成長以及醫療保健領域的持續改進。
The global binder excipients market size reached USD 1.53 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.18 Billion by 2033, exhibiting a growth rate (CAGR) of 3.82% during 2025-2033. The increasing demand for oral medications among the masses, the growing focus on patient-centric formulations, and extensive research and development activities represent some of the key factors driving the market.
Binder excipients act as one of the essential components in pharmaceutical formulations, especially when utilized in solid oral dose forms. They are employed to bind the pharmaceutical active substances and other elements of a tablet or capsule, resulting in a stable and manageable final product. They are hydrophilic molecules that can generate potent intermolecular interactions with the other components of the formulation, such as cellulose derivatives. Enhancing the powder mixture's compressibility is one of the primary purposes of binder excipients, which provide tablets or capsules with the constant size and shape possible, guaranteeing a consistent and predictable dose. Additionally, they aid in enhancing the powder mixture's flow characteristics, making it simpler to compress tablets or fill capsules. They also aid in controlling the release of the active ingredient release is another crucial function of binder excipients as well as they help in maintaining the therapeutical effect of the medicinal drugs, which is crucial for medications to have a limited therapeutic window or are absorbed only in certain parts of the body. There are several types of binder excipients available, including natural and synthetic polymers, sugars, and starches
The escalating demand for oral medicines among the patients majorly drives the global market. This is due to their several benefits, such as easy administration, convenience, and accurate dosing, which are driving the market. In addition, numerous pharmaceutical companies are investing heavily in the development of new tablet and capsule formulations, which is propelling the demand for binder excipients. Along with this, the growing focus on patient-centric formulations, which are created to improve patient compliance and adherence to a medication regimen, is significantly supporting the market. In line with this, the development of novel drug delivery systems, such as modified-release tablets and capsules, requiring specialized binder excipients is also providing a thrust to the demand. Apart from this, the growing demand for nutraceuticals, which are dietary supplements that offer health benefits, is influencing the market favorably. In addition, the rising demand for generic drugs on account of the increasing number of patents expiring on branded drugs is contributing to the market. Furthermore, the development of novel excipients, such as co-processed excipients, is creating a positive market outlook. Some of the other factors driving the market include the rising demand for innovative therapies and continual improvements in the healthcare sector.